ALTHX fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Theranexus SA engages in the design and development of drug candidates affecting the interaction between neurons and glial cells. It offers psychotropic drugs for the treatment of neurological disorders such as narcolepsy, Parkinson's disease, Alzheimer's disease, neuropathic pain, psychiatric conditions, and epilepsy. The company was founded by Franck Joseph Louis Mouthon and Mathieu Bernard Mari Charveriat on March 19, 2013 and is headquartered in Lyon, France.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
ALTHX does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company